These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5554461)

  • 1. Therapeutic activity of narcissus alkaloid on Rauscher leukemia and comparison with standard drugs.
    Furusawa E; Furusawa S; Morimoto S; Cutting W
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1168-73. PubMed ID: 5554461
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of long-term administration of narcissus alkaloid on Rauscher leukemia and combinations with standard drugs.
    Furusawa E; Suzuki N; Ramanathan S; Furusawa S; Cutting W
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):1034-40. PubMed ID: 5039364
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic activity of narcissus alkaloids on Rauscher leukemia: antiviral effect in vitro and rational drug combination in vivo.
    Suzuki N; Tani S; Furusawa S; Furusawa E
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):771-7. PubMed ID: 4131944
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapeutic trials in Rauscher Virus-induced leukemia].
    Seidel HJ; Grundmann E
    Eur J Cancer (1965); 1969 Feb; 5(1):15-24. PubMed ID: 5780169
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic activity of pretazettine, a narcissus alkaloid on Rauscher leukemia: comparison with tazettine and streptonigrin.
    Furusawa E; Furusawa S; Lee JY; Patanavanich S
    Proc Soc Exp Biol Med; 1976 Jun; 152(2):186-91. PubMed ID: 935182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic activity of pretazettine on Rauscher leukemia: comparison with the related Amaryllidaceae alkaloids.
    Furusawa E; Irie H; Combs D; Wildman WC
    Chemotherapy; 1980; 26(1):36-45. PubMed ID: 7353439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy of Rauscher leukemia and ascites tumors by narcissus alkaloid with standard drugs and effect on cellular immunity.
    Furusawa E; Suzuki N; Furusawa S; Lee JY
    Proc Soc Exp Biol Med; 1975 Jul; 149(3):771-8. PubMed ID: 49897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.
    CHIRIGOS MA; RAUSCHER FJ; KAMEL IA; FANNING GR; GOLDIN A
    Cancer Res; 1963 Nov; 23():1646-50. PubMed ID: 14098904
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic activity of pretazettine, a narcissus alkaloid, on spontaneous AKR leukemia.
    Furusawa E; Lockwood RH; Furusawa S; Lum MK; Lee JY
    Chemotherapy; 1979; 25(5):308-15. PubMed ID: 225136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental inhibition of the virus-induced Rauscher leukemia of the mouse.
    Seidel HJ
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):9-17. PubMed ID: 5659740
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral nucleated cell count as a method of assessing the response of antileukemic agents in Rauscher virus-diseased mice.
    Mishra LC; Hebborn P
    Oncology; 1973; 28(3):260-8. PubMed ID: 4767111
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
    Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
    Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic activity of pretazettine on Rauscher leukemia: combination of antiviral activity and cellular protein inhibition.
    Furusawa E; Furusawa S; Lee JY; Patanavanich S
    Chemotherapy; 1978; 24(4):259-66. PubMed ID: 648237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and murine leukemia. V. Effect of interferon preparations on the evolution of Rauscher disease in mice.
    Gresser I; Berman L; De Thé G; Brouty-Boyé D; Coppey J; Falcoff E
    J Natl Cancer Inst; 1968 Aug; 41(2):505-22. PubMed ID: 5671288
    [No Abstract]   [Full Text] [Related]  

  • 15. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS.
    CHIRIGOS MA
    Cancer Res; 1964 Jul; 24():1035-41. PubMed ID: 14198243
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of Rauscher virus-induced leukemia by L-asparaginase.
    Campbell WF; Levine AS
    Life Sci; 1969 Oct; 8(20):1033-40. PubMed ID: 5355416
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of protamine on a murine leukemia virus.
    Bates HA; Amatuzio DS; Hay L; Conklin DJ; Becker FB
    Br J Cancer; 1971 Mar; 25(1):130-4. PubMed ID: 5581291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current studies on the therapy of experimental leukemia.
    Chirigos MA
    Bibl Haematol; 1970; (36):278-92. PubMed ID: 4950966
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of immunologic hyperstimulation on murine viral leukemogenesis.
    Siegel BV; Morton JI
    Blood; 1967 Apr; 29(4):Suppl:585-93. PubMed ID: 6022295
    [No Abstract]   [Full Text] [Related]  

  • 20. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.